Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Gibson

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
The Australian and New Zealand Journal of Surgery|March 1, 1993
Chronic hepatic encephalopathy following portacaval shunt: management by loop ileostomyG S Hebbard, A W Jenney, P R Gibson, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy?E Newnham, E Hawkes, A Surender, et al.
Australian and New Zealand Journal of Medicine|February 1, 1981
Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shuntP R Gibson, F J Dudley, A W Jakobovits, et al.
Gut|November 24, 1999
Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigsM J Govers, N J Gannon, F R Dunshea, et al.
Clinical and Experimental Immunology|May 1, 1984
Natural killer cells and spontaneous cell-mediated cytotoxicity in the human intestineP R Gibson, E L Dow, W S Selby, et al.
Gastroenterology|February 1, 1996
Wheat bran suppresses potato starch--potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat modelG P Young, A McIntyre, V Albert, et al.
Internal Medicine Journal|August 2, 2001
Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User GroupM Mortimore, P R Gibson, W S Selby, et al.
Alimentary Pharmacology & Therapeutics|August 9, 2014
Editorial: 'brain fog' and coeliac disease - evidence for its existence: authors' replyI T Lichtwark, E D Newnham, S R Robinson, et al.
Gastroenterology|February 1, 1989
Isolation of colonic crypts that maintain structural and metabolic viability in vitroP R Gibson, E van de Pol, L E Maxwell, et al.
The American Journal of Gastroenterology|August 16, 2017
Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase TreatmentC J Tuck, K M Taylor, P R Gibson, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
The Australian and New Zealand Journal of Surgery|March 1, 1993
Chronic hepatic encephalopathy following portacaval shunt: management by loop ileostomyG S Hebbard, A W Jenney, P R Gibson, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy?E Newnham, E Hawkes, A Surender, et al.
Australian and New Zealand Journal of Medicine|February 1, 1981
Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shuntP R Gibson, F J Dudley, A W Jakobovits, et al.
Gut|November 24, 1999
Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigsM J Govers, N J Gannon, F R Dunshea, et al.
Clinical and Experimental Immunology|May 1, 1984
Natural killer cells and spontaneous cell-mediated cytotoxicity in the human intestineP R Gibson, E L Dow, W S Selby, et al.
Gastroenterology|February 1, 1996
Wheat bran suppresses potato starch--potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat modelG P Young, A McIntyre, V Albert, et al.
Internal Medicine Journal|August 2, 2001
Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User GroupM Mortimore, P R Gibson, W S Selby, et al.
Alimentary Pharmacology & Therapeutics|August 9, 2014
Editorial: 'brain fog' and coeliac disease - evidence for its existence: authors' replyI T Lichtwark, E D Newnham, S R Robinson, et al.
Gastroenterology|February 1, 1989
Isolation of colonic crypts that maintain structural and metabolic viability in vitroP R Gibson, E van de Pol, L E Maxwell, et al.
The American Journal of Gastroenterology|August 16, 2017
Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase TreatmentC J Tuck, K M Taylor, P R Gibson, et al.
Pageof 22